image
Apellis Pharmaceuticals, Inc. APLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 17.69
-0.394 %
$ 2.22 B
Market Cap
-9.83
P/E
Price Target Average
301.36%
Revenue Forecast Estimate
19.68%
EBIT Estimate
--69.03%
Net Income Estimate
38.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Apellis Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for APLS of $71 , with forecasts ranging from a low of $39 to a high of $96 .
APLS Lowest Price Target Wall Street Target
39 USD 120.46%
APLS Average Price Target Wall Street Target
71 USD 301.36%
APLS Highest Price Target Wall Street Target
96 USD 442.68%
Price
Max Price Target
Min Price Target
Average Price Target
100100909080807070606050504040303020201010Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart APLS

image
$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart APLS

image
$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart APLS

image
$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029